Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-27 @ 11:03 PM
Study NCT ID:
NCT00875394
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2009-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-06-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-06-27
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-01
First Submit QC Date:
None
Study First Post Date:
2009-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-06-12
Results First Submit QC Date:
None
Results First Post Date:
2011-04-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-28
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL